These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11258134)

  • 1. [Anti-ulcer drug pirenzepin: new use as an aid for prevention of myopia?].
    Kienzle-Pfeilsticker H
    Klin Monbl Augenheilkd; 2001 Feb; 218(2):A29. PubMed ID: 11258134
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of form-deprivation myopia with pirenzepine: a study of drug delivery and distribution.
    Cottriall CL; McBrien NA; Annies R; Leech EM
    Ophthalmic Physiol Opt; 1999 Jul; 19(4):327-35. PubMed ID: 10645389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of pirenzepine on lens-induced myopia in the guinea-pig].
    Ouyang CH; Chu RY; Hu WZ
    Zhonghua Yan Ke Za Zhi; 2003 Jun; 39(6):348-51. PubMed ID: 12895364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of 2% pirenzepine ophthalmic gel in children with myopia: a 1-year, multicenter, double-masked, placebo-controlled parallel study.
    Siatkowski RM; Cotter S; Miller JM; Scher CA; Crockett RS; Novack GD;
    Arch Ophthalmol; 2004 Nov; 122(11):1667-74. PubMed ID: 15534128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year multicenter, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia.
    Tan DT; Lam DS; Chua WH; Shu-Ping DF; Crockett RS;
    Ophthalmology; 2005 Jan; 112(1):84-91. PubMed ID: 15629825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tolerability study of pirenzepine ophthalmic gel in myopic children.
    Bartlett JD; Niemann K; Houde B; Allred T; Edmondson MJ; Crockett RS
    J Ocul Pharmacol Ther; 2003 Jun; 19(3):271-9. PubMed ID: 12828845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling Progression of Myopia: Optical and Pharmaceutical Strategies.
    Sankaridurg P; Conrad F; Tran H; Zhu J
    Asia Pac J Ophthalmol (Phila); 2018; 7(6):405-414. PubMed ID: 30338677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pirenzepine affects scleral metabolic changes in myopia through a non-toxic mechanism.
    Truong HT; Cottriall CL; Gentle A; McBrien NA
    Exp Eye Res; 2002 Jan; 74(1):103-11. PubMed ID: 11878823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How does atropine exert its anti-myopia effects?
    McBrien NA; Stell WK; Carr B
    Ophthalmic Physiol Opt; 2013 May; 33(3):373-8. PubMed ID: 23662969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ophthalmologists should consider the causes of myopia and not simply treat its consequences.
    Flitcroft DI
    Br J Ophthalmol; 1998 Mar; 82(3):210-1. PubMed ID: 9602613
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mechanism of Smad 3 signaling pathway and connective tissue growth factor in the inhibition of form deprivation myopia by pirenzepine].
    Ji X; Zhang J; Wang Y; Sun H; Jia P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Apr; 34(4):349-55. PubMed ID: 19411755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of pirenzepine on form deprivation myopia in chicks and its possible mechanism].
    Dai SZ; Zeng JW; Wang LY
    Zhonghua Yan Ke Za Zhi; 2006 Jan; 42(1):42-7. PubMed ID: 16638280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evidence-based update on myopia and interventions to retard its progression.
    Leo SW; Young TL
    J AAPOS; 2011 Apr; 15(2):181-9. PubMed ID: 21596297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic antagonist control of myopia: a molecular search for the M1 receptor in chick.
    Yin GC; Gentle A; McBrien NA
    Mol Vis; 2004 Oct; 10():787-93. PubMed ID: 15525903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tropicamide and myopia progression.
    Iribarren R
    Ophthalmology; 2008 Jun; 115(6):1103-4; author reply 1104. PubMed ID: 18519078
    [No Abstract]   [Full Text] [Related]  

  • 16. Atropine for the treatment of childhood myopia.
    Chua WH; Balakrishnan V; Chan YH; Tong L; Ling Y; Quah BL; Tan D
    Ophthalmology; 2006 Dec; 113(12):2285-91. PubMed ID: 16996612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myopia prevention: Newton is still right.
    Siatkowski RM
    J AAPOS; 2015 Dec; 19(6):494-5. PubMed ID: 26691025
    [No Abstract]   [Full Text] [Related]  

  • 18. [Overactive bladder. New anticholinergic drug controls urinary urge].
    MMW Fortschr Med; 2004 Jul; 146(27-28):51. PubMed ID: 15526670
    [No Abstract]   [Full Text] [Related]  

  • 19. Multifocal electroretinogram in children on atropine treatment for myopia.
    Luu CD; Lau AM; Koh AH; Tan D
    Br J Ophthalmol; 2005 Feb; 89(2):151-3. PubMed ID: 15665343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Important Step Forward in Myopia Prevention: Low-Dose Atropine.
    Morgan IG; He M
    Ophthalmology; 2016 Feb; 123(2):232-233. PubMed ID: 26802703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.